Prediction of Unexplained Recurrent Miscarriages Using Thromboelastography

Int J Womens Health. 2024 Sep 27:16:1573-1581. doi: 10.2147/IJWH.S464927. eCollection 2024.

Abstract

Objective: This study investigates the thromboelastography (TEG) changes in patients with unexplained recurrent spontaneous abortion (URSA) to identify effective diagnostic markers for URSA.

Methods: We retrospectively analyzed 160 URSA patients from the Gynecology Department of the First People's Hospital of Lianyungang (June 2017 - June 2020) and compared them with 190 healthy, fertile women without adverse pregnancy histories (control group). TEG parameters were assessed using logistic regression, applying stepwise selection for model optimization. Model performance was evaluated using Receiver Operating Characteristic (ROC) curves, determining sensitivity and specificity. The Youden index identified optimal cut points for predictive probabilities.

Results: Significant differences were observed between the URSA and control groups in coagulation reaction time (R), clot formation time (K), clot formation rate (Angle-α), and maximum clot strength (MA) (P<0.05). Multivariable logistic regression identified R, Angle-α, and MA as independent URSA risk factors. The model demonstrated excellent discrimination (AUC: 0.940; 95% CI: 0.918-0.962). The optimal cut point of predictive probability (Youden index) was P=0.355, yielding a sensitivity of 0.925 and specificity of 0.795.

Conclusion: URSA patients exhibit a hypercoagulable state even when not pregnant. More research is needed to validate our findings and explore the potential clinical implications of anticoagulants in treating URSA.

Keywords: coagulation function; prothrombotic state; thromboelastography; unexplained recurrent spontaneous abortion.

Grants and funding

This work was supported by Key Talents in Maternal and Child Health Care in Lianyungang City (No. FRC202003), Special Project on Promoting Scientific and Technological Innovation in Xuzhou City in 2022 (Key Research and Development Program (Social Development) - Standardized Treatment of Key Diseases) (No. KC22096), Youth Talent Training Fund Project of the First People’s Hospital of Lianyungang (No. QN2219) and Youth Talent Training Fund Project of the First People’s Hospital of Lianyungang (No. QN202120). Dr. Yang’s research was supported by National Institute of Health/National Institute on Aging grants P30AG10161, R01AG15819, R01AG17917, R01AG033678, R01AG36042, U01AG61356, and 1RF1AG064312– 01.